Transgenic models of autoimmune disease

被引:18
作者
Boyton, RJ
Altmann, DM
机构
[1] Hammersmith Hosp, Imperial Coll Sch Med, Dept Infect Dis, Human Dis Immunogenet Grp, London W12 0NN, England
[2] Imperial Coll Sch Med, Transplantat Biol Grp, MRC, Ctr Clin Sci, London W12 0NN, England
关键词
autoimmunity; HLA; transgenic mouse;
D O I
10.1046/j.1365-2249.2002.01771.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transgenic and knockout mouse models have been invaluable for the elucidation of basic mechanisms in autoimmunity and have contributed new experimental models of human autoimmune diseases. Transgenic models of self tolerance have helped to change our view of this state from a process mediated purely by thymic deletion to a more complex process encompassing deletion, peripheral anergy, down-regulation of receptors and modulation by regulatory cells. Experiments in which the genes for the candidate target antigens in autoimmune disease are over-expressed or under-expressed have helped to clarify the targets of attack. Several examples of T cell receptor transgenic mice have been described in which T cells carry the receptor derived from a human or mouse autoimmune T cell clone. Such mice allow the characterization of T cell specificities contributing to disease and of the additional factors and checkpoints influencing disease development. In addition, the expression of disease associated HLA alleles in 'humanised' transgenic lines allows the mapping of HLA-restricted T cell epitopes and investigation of the mechanisms underlying these genetic associations. These approaches are leading to the generation of new disease models, offering hope for the design and testing of novel immunotherapeutic strategies.
引用
收藏
页码:4 / 11
页数:8
相关论文
共 62 条
[21]   Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein [J].
Goverman, J .
IMMUNOLOGICAL REVIEWS, 1999, 169 :147-159
[22]   TRANSGENIC MICE THAT EXPRESS A MYELIN BASIC PROTEIN-SPECIFIC T-CELL RECEPTOR DEVELOP SPONTANEOUS AUTOIMMUNITY [J].
GOVERMAN, J ;
WOODS, A ;
LARSON, L ;
WEINER, LP ;
HOOD, L ;
ZALLER, DM .
CELL, 1993, 72 (04) :551-560
[23]   A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex [J].
Haines, JL ;
TerMinassian, M ;
Bazyk, A ;
Gusella, JF ;
Kim, DJ ;
Terwedow, H ;
PericakVance, MA ;
Rimmler, JB ;
Haynes, CS ;
Roses, AD ;
Lee, A ;
Shaner, B ;
Menold, M ;
Seboun, E ;
Fitoussi, RP ;
Gartioux, C ;
Reyes, C ;
Ribierre, F ;
Gyapay, G ;
Weissenbach, J ;
Hauser, SL ;
Goodkin, DE ;
Lincoln, R ;
Usuku, K ;
GarciaMerino, A ;
Gatto, N ;
Young, S ;
Oksenberg, JR .
NATURE GENETICS, 1996, 13 (04) :469-471
[24]   SPONTANEOUS INFLAMMATORY DISEASE IN TRANSGENIC RATS EXPRESSING HLA-B27 AND HUMAN BETA-2M - AN ANIMAL-MODEL OF HLA-B27-ASSOCIATED HUMAN DISORDERS [J].
HAMMER, RE ;
MAIKA, SD ;
RICHARDSON, JA ;
TANG, JP ;
TAUROG, JD .
CELL, 1990, 63 (05) :1099-1112
[25]  
Herman AE, 1999, J IMMUNOL, V163, P6275
[26]   Transgenic mouse models of rheumatoid arthritis [J].
Holmdahl, R ;
Andersson, EC ;
Andersen, CB ;
Svejgaard, A ;
Fugger, L .
IMMUNOLOGICAL REVIEWS, 1999, 169 :161-173
[27]   HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis [J].
Ito, K ;
Bian, HJ ;
Molina, M ;
Han, JH ;
Magram, J ;
Saar, E ;
Belunis, C ;
Bolin, DR ;
Arceo, R ;
Campbell, R ;
Falcioni, F ;
Vidovic, D ;
Hammer, J ;
Nagy, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2635-2644
[28]   Different modes of pathogenesis in T-cell-dependent autoimmunity:: clues from two TCR transgenic systems [J].
Ji, H ;
Korganow, AS ;
Mangialaio, S ;
Höglund, P ;
André, I ;
Lühder, F ;
Gonzalez, A ;
Poirot, L ;
Benoist, C ;
Mathis, D .
IMMUNOLOGICAL REVIEWS, 1999, 169 :139-146
[29]   STRONG XENOGENEIC HLA RESPONSE IN TRANSGENIC MICE AFTER INTRODUCING AN ALPHA-3 DOMAIN INTO HLA-B27 [J].
KALINKE, U ;
ARNOLD, B ;
HAMMERLING, GJ .
NATURE, 1990, 348 (6302) :642-644
[30]   HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice [J].
Kawamura, K ;
Yamamura, T ;
Yokoyama, K ;
Chui, DH ;
Fukui, Y ;
Sasazuki, T ;
Inoko, H ;
David, CS ;
Tabira, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :977-984